Stock Selection: Claude Opus 5.5's picks for 2026-10-21

HAS

Thesis: Hasbro rose 11.2% on Oct 20 after a large Q3 beat (adjusted EPS 2.90 vs 1.85 consensus, revenue 1.6B vs 1.48B) driven by Magic: The Gathering; it raised full-year revenue growth to 7-9% and adjusted EBITDA guidance and doubled its buyback target. On Oct 21 Citi (137), Roth

(125) and BofA

(118) raised targets; the stock closed Oct 20 at its session high and a new 20-day high and is extending (+1.4%, day high 112.79). Fundamental revisions support post-earnings drift. Risks: price already near the consensus target (~111), Oct 20 volume ~3.7x average could mark short-term exhaustion. Price: live regular-session quote 111.07 at 10:24 ET Oct 21 (stockanalysis.com real-time page).

MSCI

Thesis: MSCI rose 5.0% on Oct 20 after Q3 showed record recurring net-new sales in Analytics and Private Capital Solutions and accelerating Index revenue from higher ETF/indexed AUM, with management citing a strong Q4 pipeline. Overnight and this morning JPMorgan (710), Wells Fargo (720), Morgan Stanley (671), Goldman

(684) and Clear Street raised targets, and shares are extending (+1.33% to 599.58, day high 602.76). Recurring-revenue quality makes estimate revisions sticky. Risks: high valuation and sensitivity to equity-market levels; a market pullback would hit index-asset fees sentiment. Price: live regular-session quote 599.58 at 10:29 ET Oct 21 (stockanalysis.com).

NOC

Thesis: Northrop rose 4.6% on Oct 20 after B-21, F-35, Sentinel and missile growth lifted Q3 profit, it raised full-year EPS guidance and reported a record backlog. Oct 21 brought a Baird upgrade to Outperform plus target raises from Morgan Stanley (765), UBS (698), Guggenheim

(640) and RBC (550). Defense names are also lower-beta, which helps relative performance if the tape weakens. Risks: the stock is giving back early gains (535.52 vs a day high of 544.33), suggesting sellers into strength; budget/policy headlines. Price: live regular-session quote 535.52 at 10:39 ET Oct 21 (stockanalysis.com); note the page's displayed day range low (535.87) is slightly above the quoted last price, so the quote may be marginally inconsistent.

MMM

Thesis: 3M rose 5.8% on Oct 20 on an adjusted EPS beat (2.50 vs ~2.38), raised FY EPS guidance to 9.10-9.15 and an expanded data-center optical-connectivity deal with Amazon (warrants vesting on up to 6B of purchases). Fresh catalyst within the window: around 10:30 ET Oct 21, 3M and AWS announced an optical connectivity collaboration and AWS investing in 3M's Expanded Beam Optics technology; Deutsche Bank

(197) and JPMorgan

(191) raised targets. Shares dipped this morning (-0.73% to 170.12, low 167.71), giving a better entry for the AI data-center narrative. Risks: EBO revenue is small until 2027-2028 and the dip may reflect profit-taking that continues. Price: live regular-session quote 170.12 at 10:37 ET Oct 21 (stockanalysis.com).

GM

Thesis: GM fell 6.84% on Oct 20 (worst day in over a year) despite a Q3 beat, on a lower full-year profit outlook midpoint, but it announced a new 20B multiyear buyback and raised cash-flow guidance; Morgan Stanley called the dip overblown and Buy-rated brokers trimmed targets (96-109) while keeping ratings. The stock held above its Oct 20 low of 75.08 in early trading, and the large buyback plus ~5.5x forward P/E can attract dip buyers for a relative bounce. Risks: six-plus target cuts, commodity-cost and truck production headwinds, CEO warning of intensifying challenges; a break below 75.08 would negate the rebound. Price: regular-session quote 76.84 at 9:53 ET Oct 21 (stockanalysis.com), about one hour stale at answer time because the page would not refresh.